Improvement of the insulin secretion from beta cells encapsulated in alginate/poly-L- histidine/alginate microbeads by platelet-rich plasma

Type 1 diabetes is clinically characterized as the loss of control of glucose homeostasis due to the reduced number of insulinproducing cells. Long-term glycemic control after implantation could be maintained by preserving the cell viability and tissue-specific functions during the process of microencapsulation. In this study, alginate solution was supplemented with platelet-rich plasma (PRP) to improve the viability and preserve the cell functions during the encapsulation of a beta cell line (BRIN-BD11). Cell viability was assessed and insulin secretion and insulin stimulation index were evaluated. The polymerization of alginate with PRP enhanced the viability up to 61% in the alginate microbeads. PRP supplementation to the alginate composition not only increased the number of viable cells by 1.95-fold, but the insulin secretion also improved by about 66%. The stimulation index, however, was not affected by the PRP supplementation.

___

  • Ausländer D, Ausländer S, Charpin-El Hamri G, Sedlmayer F, Müller M, Frey O, Hierlemann A, Stelling J, Fussenegger M (2014). A synthetic multifunctional mammalian pH sensor and CO 2 transgene-control device. Mol Cell 55: 397-408.
  • Bhujbal SV, de Haan B, Niclou SP, de Vos P (2014). A novel multilayer immunoisolating encapsulation system overcoming protrusion of cells. Sci Rep 4: 6856.
  • Bilalis P, Tziveleka LA, Varlas S, Iatrou H (2016). pH-Sensitive nanogates based on poly(L-histidine) for controlled drug release from mesoporous silica nanoparticles. Polymer Chem 7: 1475-1485.
  • Calafiore R, Basta G, Luca G, Lemmi A, Racanicchi L, Mancuso F, Montanucci MP, Brunetti P (2006). Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc 38: 1156-1157.
  • Coue G, Engbersen JFJ (2015). Cationic polymers for intracellular delivery of proteins. In: Samal SK, Dubruel P, editors. Cationic Polymers in Regenerative Medicine. 1st ed. Cambridge, UK: Royal Society of Chemistry, pp. 370-376.
  • Desai T, Shea LD (2017). Advances in islet encapsulation technologies. Nat Rev Drug Discov 16: 338-350.
  • de Vos P, Bucko M, Gemeiner P, Navrátil M, Svitel J, Faas M, Strand BL, Skjak-Braek G, Morch YA, Vikartovská A et al. (2009). Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 30: 2559-2570.
  • Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T (2014). Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J 4: 3-9.
  • Duruksu G, Aciksari A (2018). Guiding the differentiation direction of pancreatic islet derived stem cells by glycated collagen. Stem Cells Int 2018: 6143081.
  • Gao ZG, Lee DH, Kim DI, Bae YH (2005). Doxorubicin loaded pH- sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. J Drug Target 13: 391-397.
  • Horimizu M, Kawase T, Nakajima Y, Okuda K, Nagata M, Wolff LF, Yoshie H (2013). An improved freeze-dried PRP- coated biodegradable material suitable for connective tissue regenerative therapy. Cryobiology 66: 223-232.
  • Jacobs-Tulleneers-Thevissen D, Chintinne M, Ling Z, Gillard P, Schoonjans L, Delvaux G, Strand BL, Gorus F, Keymeulen B, Pipeleers D (2013). Beta Cell Therapy Consortium EU-FP7. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 56: 1605-1614.
  • Kakudo N, Morimoto N, Kushida S, Ogawa T, Kusumoto K (2014). Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo. Med Mol Morphol 47: 83-89.
  • Kushida S, Kakudo N, Morimoto N, Hara T, Ogawa T, Mitsui T, Kusumoto K (2014). Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs 17: 186-192.
  • Lee ES, Na K, Bae YH (2003a). Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release 91: 103-113.
  • Lee ES, Oh KT, Kim D, Youn YS, Bae YH (2007). Tumor pH- responsive flower-like micelles of poly(L-lactic acid)-b- poly(ethylene glycol)-b-poly(L-histidine). J Control Release 123: 19-26.
  • Lee ES, Shin HJ, Na K, Bae YH (2003b). Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release 90: 363-374.
  • Man Y, Wang P, Guo Y, Xiang L, Yang Y, Qu Y, Gong P, Deng L (2012). Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres. Biomaterials 33: 8802-8811.
  • Nagata MJ, Messora MR, Furlaneto FA, Fucini SE, Bosco AF, Garcia VG, Deliberador TM, de Melo LG (2010). Effectiveness of two methods for preparation of autologous platelet-rich plasma: an experimental study in rabbits. Eur J Dent 4: 395-402.
  • Okuda K, Tai H, Tanabe K, Suzuki H, Sato T, Kawase T, Saito Y, Wolff LF, Yoshiex H (2005). Platelet-rich plasma combined with a porous hydroxyapatite graft for the treatment of intrabony periodontal defects in humans: a comparative controlled clinical study. J Periodontol 76: 890-898.
  • Orive G, Santos E, Pedraz JL, Hernández RM (2014). Application of cell encapsulation for controlled delivery of biological therapeutics. Adv Drug Deliv Rev 67: 3-14.
  • Prokop A, Hunkeler D, DiMari S, Haralson MA, Wang TG (1998). Water soluble polymers for immunoisolation I: Complex coacervation and cytotoxicity. Adv Polym Sci 136: 1-51.
  • Prüsse U, Bilancetti L, Bucko M, Bugarski B, Bukowski J, Gemeiner P, Lewinska D, Manojlovic V, Massart B, Nastruzzi C et al. (2008). Comparison of different technologies for alginate beads production. Chemical Papers 62: 364-374.
  • Robles L, Storrs R, Lamb M, Alexander M, Lakey JR (2014). Current status of islet encapsulation. Cell Transplant 23: 1321-1348.
  • Sarker B, Papageorgiou DG, Silva R, Zehnder T, Gul-E-Noor F, Bertmer M, Kaschta J, Chrissafis K, Detsch R, Boccaccini AR (2014). Fabrication of alginate-gelatin crosslinked hydrogel microcapsules and evaluation of the microstructure and physio-chemical properties. J Mater Chem B 2: 1470-1482.
  • Strand BL, Ryan TL, In’t Veld P, Kulseng B, Rokstad AM, Skjak-Brek G, Espevik T (2001). Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 10: 263-275.
  • van Schilfgaarde R, de Vos P (1999). Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med (Berl) 77: 199-205.
  • Wu H, Zhu L, Torchilin VP (2013). pH-sensitive poly(histidine)- PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 34: 1213-1222.
  • Zimmermann U, Cramer H, Jork A, Thurmer F, Zimmermann H, Fuhr G, Hasse C, Rothmund M (2001). Microencapsulation- based cell therapy. In: Rehm HJ, Reed G, editors. Biotechnology: Special Processes. 1st ed. Weinheim, Germany: Wiley Press, pp. 547-571.